FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945263797> ?p ?o ?g. }

• W2945263797 endingPage "1802" @default.
• W2945263797 startingPage "1798" @default.
• W2945263797 abstract "Prognosis of patients with graft failure is dismal, and retransplantation is the sole option for long-term survival. To address the interest of haploidentical transplantation as a salvage option in this context, we analyzed data from 24 patients with graft failure or loss retransplanted with a haploidentical donor who received post-transplant cyclophosphamide (PTCy) as graft-versus-host disease prophylaxis (GVHD). Fludarabine-based reduced-intensity conditioning was used in 23 patients and the Baltimore regimen in 14 patients. The median delay between previous and salvage transplantation for graft failure was 63 days (range, 39 to 98). In addition to PTCy, all patients received cyclosporine, and 22 patients also received mycophenolate mofetil for GVHD prophylaxis. With a median follow-up of 353 days (range, 16 to 2010), 1-year overall survival (OS) was 56% (95% confidence interval, 38% to 81%). Transplant complications accounted for 80% of deaths. The cumulative incidence of neutrophil engraftment at day +30 was 79%. Cumulative incidence of grades II to IV acute GVHD at day 100 was 14%, and 1-year cumulative incidence of chronic GVHD was 31%. One-year cumulative incidence of relapse was 13%. Stem cell source did not impact on engraftment, GVHD, relapse, or OS. Salvage haploidentical transplant with PTCy for rescuing graft failure patients leads to an acceptable 1-year OS and might be a valid option in this poor situation." @default.
• W2945263797 created "2019-05-29" @default.
• W2945263797 creator A5001526915 @default.
• W2945263797 creator A5006102363 @default.
• W2945263797 creator A5011865826 @default.
• W2945263797 creator A5012691135 @default.
• W2945263797 creator A5020996390 @default.
• W2945263797 creator A5022161221 @default.
• W2945263797 creator A5025925500 @default.
• W2945263797 creator A5026054699 @default.
• W2945263797 creator A5027624956 @default.
• W2945263797 creator A5034473496 @default.
• W2945263797 creator A5036207495 @default.
• W2945263797 creator A5042277356 @default.
• W2945263797 creator A5058527857 @default.
• W2945263797 creator A5071217362 @default.
• W2945263797 creator A5072757261 @default.
• W2945263797 creator A5080673678 @default.
• W2945263797 creator A5084993767 @default.
• W2945263797 creator A5086403776 @default.
• W2945263797 creator A5091697243 @default.
• W2945263797 date "2019-09-01" @default.
• W2945263797 modified "2023-09-29" @default.
• W2945263797 title "Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy" @default.
• W2945263797 cites W1978164777 @default.
• W2945263797 cites W2039334806 @default.
• W2945263797 cites W2058009140 @default.
• W2945263797 cites W2071068942 @default.
• W2945263797 cites W2091661505 @default.
• W2945263797 cites W2101411993 @default.
• W2945263797 cites W2183761855 @default.
• W2945263797 cites W2255538341 @default.
• W2945263797 cites W2271160032 @default.
• W2945263797 cites W2337837694 @default.
• W2945263797 cites W2476252746 @default.
• W2945263797 cites W2769990542 @default.
• W2945263797 cites W2798245038 @default.
• W2945263797 doi "https://doi.org/10.1016/j.bbmt.2019.05.013" @default.
• W2945263797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31129355" @default.
• W2945263797 hasPublicationYear "2019" @default.
• W2945263797 type Work @default.
• W2945263797 sameAs 2945263797 @default.
• W2945263797 citedByCount "16" @default.
• W2945263797 countsByYear W29452637972020 @default.
• W2945263797 countsByYear W29452637972021 @default.
• W2945263797 countsByYear W29452637972022 @default.
• W2945263797 countsByYear W29452637972023 @default.
• W2945263797 crossrefType "journal-article" @default.
• W2945263797 hasAuthorship W2945263797A5001526915 @default.
• W2945263797 hasAuthorship W2945263797A5006102363 @default.
• W2945263797 hasAuthorship W2945263797A5011865826 @default.
• W2945263797 hasAuthorship W2945263797A5012691135 @default.
• W2945263797 hasAuthorship W2945263797A5020996390 @default.
• W2945263797 hasAuthorship W2945263797A5022161221 @default.
• W2945263797 hasAuthorship W2945263797A5025925500 @default.
• W2945263797 hasAuthorship W2945263797A5026054699 @default.
• W2945263797 hasAuthorship W2945263797A5027624956 @default.
• W2945263797 hasAuthorship W2945263797A5034473496 @default.
• W2945263797 hasAuthorship W2945263797A5036207495 @default.
• W2945263797 hasAuthorship W2945263797A5042277356 @default.
• W2945263797 hasAuthorship W2945263797A5058527857 @default.
• W2945263797 hasAuthorship W2945263797A5071217362 @default.
• W2945263797 hasAuthorship W2945263797A5072757261 @default.
• W2945263797 hasAuthorship W2945263797A5080673678 @default.
• W2945263797 hasAuthorship W2945263797A5084993767 @default.
• W2945263797 hasAuthorship W2945263797A5086403776 @default.
• W2945263797 hasAuthorship W2945263797A5091697243 @default.
• W2945263797 hasBestOaLocation W29452637971 @default.
• W2945263797 hasConcept C120665830 @default.
• W2945263797 hasConcept C121332964 @default.
• W2945263797 hasConcept C126322002 @default.
• W2945263797 hasConcept C141071460 @default.
• W2945263797 hasConcept C151730666 @default.
• W2945263797 hasConcept C2776694085 @default.
• W2945263797 hasConcept C2776755627 @default.
• W2945263797 hasConcept C2779263901 @default.
• W2945263797 hasConcept C2779343474 @default.
• W2945263797 hasConcept C2780775027 @default.
• W2945263797 hasConcept C2781413609 @default.
• W2945263797 hasConcept C2911091166 @default.
• W2945263797 hasConcept C61511704 @default.
• W2945263797 hasConcept C71924100 @default.
• W2945263797 hasConcept C86803240 @default.
• W2945263797 hasConcept C88879693 @default.
• W2945263797 hasConceptScore W2945263797C120665830 @default.
• W2945263797 hasConceptScore W2945263797C121332964 @default.
• W2945263797 hasConceptScore W2945263797C126322002 @default.
• W2945263797 hasConceptScore W2945263797C141071460 @default.
• W2945263797 hasConceptScore W2945263797C151730666 @default.
• W2945263797 hasConceptScore W2945263797C2776694085 @default.
• W2945263797 hasConceptScore W2945263797C2776755627 @default.
• W2945263797 hasConceptScore W2945263797C2779263901 @default.
• W2945263797 hasConceptScore W2945263797C2779343474 @default.
• W2945263797 hasConceptScore W2945263797C2780775027 @default.
• W2945263797 hasConceptScore W2945263797C2781413609 @default.
• W2945263797 hasConceptScore W2945263797C2911091166 @default.
• W2945263797 hasConceptScore W2945263797C61511704 @default.
• W2945263797 hasConceptScore W2945263797C71924100 @default.

• next